169 related articles for article (PubMed ID: 28395596)
1. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis.
Huang Z; Tang W; Liang Z; Chen Q; Li M; Li Y; Lao S; Pan H; Huang L; Huang M; Hu X; Zhao J
Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
[TBL] [Abstract][Full Text] [Related]
3. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
[TBL] [Abstract][Full Text] [Related]
4. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
[TBL] [Abstract][Full Text] [Related]
6. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion.
Aarabi M; Memariani T; Arefi S; Aarabi M; Hantoosh Zadeh S; Akhondi MA; Modarressi MH
J Matern Fetal Neonatal Med; 2011 Mar; 24(3):545-8. PubMed ID: 20822334
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
Schenk JF; Stephan B; Zewinger S; Speer T; Pindur G
Clin Hemorheol Microcirc; 2008; 39(1-4):329-32. PubMed ID: 18503142
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
Li YY
PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.
Zhang T; Pang C; Li N; Zhou E; Zhao K
BMC Med; 2013 Jan; 11():1. PubMed ID: 23281898
[TBL] [Abstract][Full Text] [Related]
11. Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis.
Chen H; Nie S; Lu M
Am J Reprod Immunol; 2015 Apr; 73(4):292-300. PubMed ID: 25250948
[TBL] [Abstract][Full Text] [Related]
12. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
[TBL] [Abstract][Full Text] [Related]
13. Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.
Bae SC; Lee YH
Z Rheumatol; 2020 Apr; 79(3):312-318. PubMed ID: 31428858
[TBL] [Abstract][Full Text] [Related]
14. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ
Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255
[TBL] [Abstract][Full Text] [Related]
15. PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.
Wang S; Cao Q; Wang X; Li B; Tang M; Yuan W; Fang J; Qian J; Qin C; Zhang W
PLoS One; 2013; 8(2):e56797. PubMed ID: 23437240
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
17. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal.
Wiwanitkit V
Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
Armangil D; Yurdakök M; Okur H; Gürgey A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):352-7. PubMed ID: 20460339
[TBL] [Abstract][Full Text] [Related]
19. Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis.
Su MT; Lin SH; Chen YC; Kuo PL
Thromb Haemost; 2013 Jan; 109(1):8-15. PubMed ID: 23179239
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]